8-K
filed September 10, 2025, 7:59 PM ET
ticker CELC
CIK 0001603454
debt
confidence high
sentiment positive
materiality 0.85
Celcuity Inc. (CELC): debt financing — Celcuity upsizes senior secured facility to $500M, receives $30M immediate funding
Celcuity Inc.
- Total facility increased to $500M ($350M committed + $150M discretionary); $30M funded, total outstanding $130M.
- Adds $100M upon FDA approval of gedatolisib in 2L wild-type advanced breast cancer; $120M upon commercial milestones.
- Maturity extended to Nov 1, 2029; interest-only period extended by 14 months, with possible 7-month FDA-approval extension.
- Issued warrants for 50,537 shares to lenders; cashless exercise through tenth anniversary of Term D funding.
- Funds will support NDA rolling submission via FDA's RTOR program, commercial launch prep, and strategic initiatives.
Key facts
Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Celcuity Inc. incurred term loan of $30.0 million Term D Loan with Oxford Finance LLC maturing November 1, 2029.
- Instrument
- term loan
- Principal
- $30.0 million Term D Loan
- Counterparty
- Oxford Finance LLC
- Maturity
- November 1, 2029
- Event
- incurrence
Exact text from the filing
recognize the achievement of the Term D Milestone (as defined in the A&R Loan Agreement, as amended by the Third Amendment (the "Amended A&R Loan Agreement")) and provide for the immediate disbursement of the $30.0 million Term D Loan (as defined in the Amended A&R Loan Agreement)
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Celcuity Inc. amended credit facility with Oxford Finance LLC maturing extend the maturity date of the term loans to November 1, 2029.
- Instrument
- credit facility
- Counterparty
- Oxford Finance LLC
- Maturity
- extend the maturity date of the term loans to November 1, 2029
- Event
- amendment
Exact text from the filing
greement”) with Oxford Finance LLC, a Delaware limited liability company (“Oxford”), as collateral agent and a lender,
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Celcuity Inc. amended credit facility of increase the size of the Term E Loan (as defined in the Amended A&R Loan Agreement) from $50.0 million to up to $100.0 m with Oxford Finance LLC maturing November 1, 2029.
- Instrument
- credit facility
- Principal
- increase the size of the Term E Loan (as defined in the Amended A&R Loan Agreement) from $50.0 million to up to $100.0 m
- Counterparty
- Oxford Finance LLC
- Maturity
- November 1, 2029
- Event
- amendment
Exact text from the filing
increase the size of the Term E Loan (as defined in the Amended A&R Loan Agreement) from $50.0 million to up to $100.0 million
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Celcuity Inc. amended term loan of three new $40.0 million Term F Loans with Oxford Finance LLC maturing November 1, 2029.
- Instrument
- term loan
- Principal
- three new $40.0 million Term F Loans
- Counterparty
- Oxford Finance LLC
- Maturity
- November 1, 2029
- Event
- amendment
Exact text from the filing
add three new $40.0 million Term F Loans (as defined in the Amended A&R Loan Agreement), which may only be drawn upon achievement of certain trailing three months’ product revenue thresholds
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Celcuity Inc. amended term loan of replace the prior $45.0 million Term F Loan … with a new $150.0 million Term G Loan with Oxford Finance LLC maturing November 1, 2029.
- Instrument
- term loan
- Principal
- replace the prior $45.0 million Term F Loan … with a new $150.0 million Term G Loan
- Counterparty
- Oxford Finance LLC
- Maturity
- November 1, 2029
- Event
- amendment
Exact text from the filing
replace the prior $45.0 million Term F Loan (as defined in the A&R Loan Agreement) with a new $150.0 million Term G Loan (as defined in the Amended A&R Loan Agreement)
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Celcuity Inc. issued 50,537 shares of warrant to Innovatus, Oxford, and certain of its affiliates.
- Security
- warrant
- Shares
- 50,537 shares
- Purchaser
- Innovatus, Oxford, and certain of its affiliates
Exact text from the filing
the Company issued warrants to purchase an aggregate of 50,537 shares of the Company’s common stock to Innovatus, Oxford, and certain of its affiliates (the “Warrants”)
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.